HEMORRHOIDAL OINTMENT 71.9 %
PETROLATUM : 71.9 % PHENYLEPHRINE HYDROCHLORIDE : .25 % MINERAL OIL : 14 % SHARK LIVER OIL : 3 % · DIN 02215845 · PERRIGO INTERNATIONAL
Health Canada status: CANCELLED POST MARKET
What is HEMORRHOIDAL OINTMENT?
HEMORRHOIDAL OINTMENT 71.9 % contains PETROLATUM : 71.9 % PHENYLEPHRINE HYDROCHLORIDE : .25 % MINERAL OIL : 14 % SHARK LIVER OIL : 3 %. It is listed in the Health Canada Drug Product Database under DIN 02215845, held by PERRIGO INTERNATIONAL, supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 12-Aug-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02215845 |
|---|---|
| Brand name | HEMORRHOIDAL OINTMENT |
| Generic / active ingredient | PETROLATUM : 71.9 % PHENYLEPHRINE HYDROCHLORIDE : .25 % MINERAL OIL : 14 % SHARK LIVER OIL : 3 % |
| Manufacturer | PERRIGO INTERNATIONAL |
| Strength | 71.9 % |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | C05AX03 OTHER PREPARATIONS, COMBINATIONS |
| AHFS class | 84:92.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 12-Aug-1998 |
| Original market date | 1997-01-10 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02215845 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2215845 |
| Brand name | HEMORRHOIDAL OINTMENT |
| Active ingredient / INN | PETROLATUM : 71.9 % PHENYLEPHRINE HYDROCHLORIDE : .25 % MINERAL OIL : 14 % SHARK LIVER OIL : 3 % |
| ATC code | C05AX03 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C05 |
| AHFS class | 84:92.00 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | PERRIGO INTERNATIONAL |
Which pack is which?
| Strength on the label | 71.9 % |
|---|---|
| Dosage form | OINTMENT |
| Route | TOPICAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code C05AX03 OTHER PREPARATIONS, COMBINATIONS. 2 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HEMORRHOIDAL OINTMENT | 0.25 % | OINTMENT | PERRIGO INTERNATIONAL | MARKETED | DIN 02501252 |
| PREPARATION H-PE GEL | 50 % | GEL | HALEON CANADA ULC | MARKETED | DIN 02209594 |
| FORMULATION R HEMORRHOIDAL OINTMENT | 0.25 % | OINTMENT | G&W LABORATORIES INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02246389 |
| FORMULATION R HEMORRHOIDAL SUPPOSITORIES | 5.5 MG | SUPPOSITORY | G&W LABORATORIES INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02248286 |
| HEM-RELIEF ONT | 85 % | OINTMENT | NATURE'S WAY OF CANADA LTD. | CANCELLED POST MARKET | DIN 00656259 |
| HEMORRHOIDAL COOLING GEL | 0.25 % | GEL | G&W LABORATORIES INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02327287 |
| HEMORRHOIDAL RELIEF OINTMENT | 0.25 % | OINTMENT | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | DIN 02230466 |
| HEMORRHOIDAL SUPPOSITORIES | 3.0 % | SUPPOSITORY | TRIAD PHARMACEUTICALS | CANCELLED POST MARKET | DIN 02290065 |
| HEMORRHOIDAL SUPPOSITORIES | 85.5 % | SUPPOSITORY | PHARMA PAC LLC | CANCELLED POST MARKET | DIN 02382156 |
| NUMB SQUEEZE | 0.25 % | GEL | LALANI RX CONSULTING INC. | APPROVED | DIN 02534010 |
Who else supplies OTHER PREPARATIONS, COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OTHER PREPARATIONS, COMBINATIONS appears in 8 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.